IMA-204

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameIMA-204

Drug Alias NameIMA-204

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicityCollagen alpha-3(VI) chain inhibitors

TargetsCollagen alpha-3(VI) chain

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmatics Us Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmatics Us Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A